Why Stryker Stock Rose Today

Stryker Corporation SYK shares traded higher on Monday. The stock may have been rebounding after falling last week following FDA establishment of a Digital Health Advisory Committee.

What To Know: Last Wednesday, shares of Stryker fell alongside other healthcare stocks on the announcement of the committee, which is intended to advise the U.S. Food and Drug Administration (FDA) on topics related to digital health technologies (DHTs). Shares of the stock continued to slide into Thursday following the news as well.

However, the stock began to rebound from the selloff last Friday, a move which continued on Monday.

Related Link: Why Harmony Biosciences Stock Is Trading Higher Today

SYK Price Action: Shares of SYK were flat in the after-hours session at the time of publication, according to Benzinga Pro.

Image by Marijana from Pixabay

SYK Logo
SYKStryker Corp
$367.990.41%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
74.47
Growth
63.56
Quality
62.53
Value
2.16
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs

Posted In:
Comments
Loading...